SLC5A4
protein-codingsolute carrier family 5 member 4, the group of Solute carrier family 5
Gene summary
Predicted to enable low-affinity D-glucose:sodium symporter activity and proton transmembrane transporter activity. Predicted to be involved in D-glucose import across plasma membrane and renal D-glucose absorption. Predicted to act upstream of or within proton transmembrane transport. Predicted to be located in membrane. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Jun 2026]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~36.9 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
No GenCC data available for this gene.
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to SLC5A4 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_014227.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 3 | 5 | |||
| missense | 95 | 6 | 101 | |||
| nonsense | 1 | 1 | ||||
| start loss | 0 | |||||
| frameshift | 1 | 1 | ||||
| splice donor/acceptor (+/-2bp) | 2 | 2 | ||||
| Total | 0 | 0 | 100 | 10 | 0 | 110 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_055042.1 | 15 | MANE Select | |
| Ensembl | ENSP00000266086.3 | 15 | MANE Select | |
| Ensembl | ENSP00000803834.1 | 15 | Standard | |
| RefSeq | XP_006724371.1 | 14 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Nuclear Receptors Meta-Pathway
- NRF2 pathway
- SLC-mediated transmembrane transport
- Transport of small molecules
- Cellular hexose transport
Biological Process
- sodium ion transport
- glucose transmembrane transport
Molecular Function
- glucose:sodium symporter activity
Cellular Component
- plasma membrane
- integral component of membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000266086
- Coding exons
- 15
- Length
- 36864
- Individuals with no LoFs
- 121728
- Homozygous LoFs
- 47
- Heterozygous LoFs
- 3973
- Defined
- 125748
- p
- 0.0161
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.839 | 342 | 389 | 0.880 | 0.0000215 | 4271 |
| Missense (PolyPhen) | 113 | 147.33 | 0.76696 | 1668 | ||
| Synonymous | 0.793 | 137 | 149 | 0.917 | 0.00000913 | 1330 |
| Loss of Function | 0.936 | 28 | 33.9 | 0.826 | 0.00000187 | 360 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.0067 | 0.0047 | notable |
| Latino/Admixed American | 0.016 | 0.0087 | notable |
| Ashkenazi Jewish | 0.0070 | 0.0042 | notable |
| East Asian | 0.032 | 0.030 | notable |
| Finnish | 0.0079 | 0.0045 | notable |
| European (Non-Finnish) | 0.023 | 0.014 | notable |
| South Asian | 0.045 | 0.042 | notable |
| Other | 0.025 | 0.015 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Has electrogenic activity in response to glucose, and may function as a glucose sensor (PubMed:13130073, PubMed:17110502, PubMed:20421923, PubMed:22766068). Mediates influx of sodium ions into the cell but does not transport sugars (PubMed:13130073, PubMed:22766068). Also potently activated by imino sugars such as deoxynojirimycin (DNJ) (PubMed:17110502, PubMed:20421923, PubMed:22766068). {ECO:0000269|PubMed:13130073, ECO:0000269|PubMed:17110502, ECO:0000269|PubMed:20421923, ECO:0000269|PubMed:22766068}.;
Recessive Scores
- pRec
- 0.112
Intolerance Scores
- LoFtool
- 0.187
- RVIS EVS
- 0.74
- RVIS percentile EVS
- 86.33
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.157
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |